Scholtz & Company LLC decreased its holdings in shares of NutriSystem Inc (NASDAQ:NTRI) by 6.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,590 shares of the company’s stock after selling 4,120 shares during the quarter. NutriSystem accounts for approximately 2.7% of Scholtz & Company LLC’s holdings, making the stock its 15th biggest position. Scholtz & Company LLC owned approximately 0.20% of NutriSystem worth $3,102,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlueCrest Capital Management Ltd acquired a new stake in shares of NutriSystem in the second quarter worth about $262,000. State Street Corp lifted its position in shares of NutriSystem by 10.6% in the second quarter. State Street Corp now owns 846,058 shares of the company’s stock worth $44,035,000 after buying an additional 81,175 shares during the last quarter. AHL Partners LLP acquired a new stake in shares of NutriSystem in the second quarter worth about $513,000. Balyasny Asset Management LLC acquired a new stake in shares of NutriSystem in the second quarter worth about $13,190,000. Finally, Stifel Financial Corp acquired a new stake in shares of NutriSystem in the second quarter worth about $1,140,000. 92.59% of the stock is owned by hedge funds and other institutional investors.

NutriSystem Inc (NASDAQ:NTRI) traded up 1.52% during trading on Friday, hitting $56.65. The company had a trading volume of 145,444 shares. NutriSystem Inc has a one year low of $29.35 and a one year high of $67.95. The stock has a market capitalization of $1.69 billion, a PE ratio of 35.10 and a beta of 1.15. The stock has a 50-day moving average of $53.60 and a 200-day moving average of $53.17.

NutriSystem (NASDAQ:NTRI) last issued its quarterly earnings data on Wednesday, July 26th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.18. NutriSystem had a net margin of 7.60% and a return on equity of 48.41%. The firm had revenue of $194.90 million during the quarter, compared to the consensus estimate of $180.75 million. During the same period last year, the business posted $0.54 earnings per share. The business’s revenue for the quarter was up 30.1% compared to the same quarter last year. On average, equities analysts anticipate that NutriSystem Inc will post $1.91 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “NutriSystem Inc (NTRI) Shares Sold by Scholtz & Company LLC” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/nutrisystem-inc-ntri-shares-sold-by-scholtz-company-llc/1613193.html.

In related news, Director Robert F. Bernstock sold 7,000 shares of NutriSystem stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $53.26, for a total value of $372,820.00. Following the transaction, the director now directly owns 25,350 shares of the company’s stock, valued at $1,350,141. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Dawn M. Zier sold 30,121 shares of NutriSystem stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $52.27, for a total transaction of $1,574,424.67. Following the completion of the transaction, the insider now directly owns 214,646 shares in the company, valued at $11,219,546.42. The disclosure for this sale can be found here. Over the last quarter, insiders sold 117,556 shares of company stock valued at $6,257,010. 2.40% of the stock is owned by company insiders.

A number of analysts have weighed in on NTRI shares. Craig Hallum set a $80.00 price target on NutriSystem and gave the stock a “buy” rating in a research report on Thursday, July 27th. BidaskClub raised NutriSystem from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, July 19th. Zacks Investment Research raised NutriSystem from a “hold” rating to a “strong-buy” rating and set a $64.00 price target for the company in a research report on Saturday, July 29th. Barrington Research raised NutriSystem from a “market perform” rating to an “outperform” rating and set a $65.00 price target for the company in a research report on Monday, July 31st. Finally, DA Davidson reaffirmed a “buy” rating and issued a $64.00 price target on shares of NutriSystem in a research report on Monday, July 24th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $68.11.

NutriSystem Company Profile

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Want to see what other hedge funds are holding NTRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NutriSystem Inc (NASDAQ:NTRI).

Institutional Ownership by Quarter for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.